About BiosanaPharma

We are a biopharmaceutical company focused on reducing the manufacturing costs of (biosimilars of) Monoclonal Antibody (mAbs) biological drugs, in order to increase patient access to this important family of therapeutics. We have developed technology capable of reducing the COGS more than 10-fold, which allows healthy profitability even at 50% of the pricing of originator drugs. We are scaling up our platform to commercialize it to third parties and we are also developing our own pipeline of biosimilar products. We aim to become a global reference in the manufacturing of monoclonal antibody biologicals, biosimilars and biobetters.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
Bargelaan 200, Leiden, South Holland 2333CW, NL
description icon
Founded
2012
description icon
Keywords
Biotechnology, Monoclonal Antibodies, Biosimilar Mabs, Low Cost Of Goods

BiosanaPharma Alternatives

Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about BiosanaPharma

Who is the CEO of BiosanaPharma?

Ard Tijsterman is the CEO of BiosanaPharma. To contact Ard Tijsterman email at [email protected].

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more